Lanvin Group gets NYSE price notice, has until May 2027 to cure

SHANGHAI — November 13, 2026 -- Lanvin Group Holdings Limited (NYSE: LANV) received a notice from the New York Stock Exchange on November 10, 2026 that its ordinary shares fall short of the exchange's minimum average closing price of US$1.00 over a consecutive 30 trading-day period. The company disclosed the notice three days later.

The cure period runs six months from receipt of the letter, which by our calculation ends around May 10, 2027. Lanvin Group says it has told the NYSE it intends to cure the deficiency, and that it can regain compliance at any point in the window.

The test is applied at month-end. On the last trading day of any calendar month in the cure period, the shares must close at or above US$1.00 and average at least US$1.00 over the 30 trading days ending that day. By our calculation, six such dates fall inside the window, from November 30, 2026 to April 30, 2027.

The company says it will consider alternatives, including a reverse stock split, if necessary. A split requires shareholder approval. The company did not disclose a timetable for any shareholder vote.

Lanvin Group says the notice has no immediate effect on the listing and is not expected to affect operations. The shares continue to trade under "LANV" during the cure period, subject to the company meeting the NYSE's other continued listing requirements. The company points to the risk factors in its annual report on Form 20-F for fiscal 2025, filed with the SEC on April 30, 2026, for further uncertainties.

Published by:
fairsonline_team
Industries